An error occurred retrieving publication content to display, please try again.
Page not found (404)
Sorry - the page you requested could not be found.
Please choose a page from the navigation or try a website search above to find the information you need.
Toolkit
Six days of daily low-dose prednisolone during an upper respiratory tract infection does not reduce associated relapse of steroid sensitive nephrotic syndrome in UK children.
1 Department of Paediatric Nephrology, Nottingham Children’s Hospital, Nottingham, UK
2 Department of Paediatric Nephrology, University of Manchester, Academic Health Science Centre, Royal Manchester Children’s Hospital, Manchester, UK
3 Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK
4 Health Economics Unit, University of Birmingham, Birmingham, UK
5 Department of Paediatric Nephrology, Birmingham Children’s Hospital, Birmingham, UK
6 Department of Renal Medicine, University College London, Department of Paediatric Nephrology, Great Ormond Street Hospital for Children, London, UK
7 School of Clinical Sciences, University of Bristol, Department of Paediatric Nephrology, Bristol Royal Hospital for Children, Bristol, UK
8 Leicester Children’s Hospital, Leicester, UK
9 Child Health Clinical Academic Group, King’s College London, Department of Paediatric Nephrology, Evelina London Children’s Hospital, London, UK
10 Department of Paediatric Nephrology, Royal Hospital for Sick Children, Glasgow, UK
11 Department of Paediatric Nephrology, University Hospital of Wales, Cardiff, UK
12 Department of Paediatric Nephrology, Leeds Children’s Hospital, Leeds, UK
13 Department of Paediatric Nephrology, Southampton Children’s Hospital, Southampton, UK
14 Department of Paediatric Nephrology, Alder Hey Children’s Hospital, Liverpool, UK
15 Department of Paediatric Nephrology, Royal Hospital for Sick Children, Belfast, UK
16 Nephrotic Syndrome Trust (NeST), Taunton, UK
* Corresponding author Email: martin.christian@nuh.nhs.uk
† Joint first authors
Joint first authors
Declared competing interests of authors: Martin T Christian is a member of the International Pediatric Nephrology Association Clinical Practice Guideline Group for Steroid Sensitive Nephrotic Syndrome (2020–present). Nicholas JA Webb reports personal fees from Novartis Pharma AG (Basel, Switzerland) outside the submitted work. Nafsika Afentou has received a grant from the National Institute for Health Research (NIHR) for research unrelated to this report (NIHR300440). Emma Frew has received grants from NIHR (nine in the 36 months prior to publication: NIHR300773, 03/164/51, 17/92/39, 14/185/13, 15/184/14, RP-PG-0618-20008, NIHR203012, RP-DG-1215-10002 and NIHR CDF 2015 08 013), UK Research and Innovation (London, UK) (BB/V004832/1) and Zhejiang Yongning Pharmaceutical Co., Ltd (Taizhou, The People’s Republic of China) for research unrelated to this report. Elizabeth A Brettell reports grants from NIHR during the conduct of the study. Other than the grants received for the PREDNOS (PREDnisolone in NephrOtic Syndrome) studies (reference 08/53/31), other NIHR grants received include grants for the ECUSTEC (ECUlizumab in Shiga-Toxin producing Escherichia Coli Haemolytic Uraemic Syndrome) trial (reference 14/48/43) and the GHD (Growth Hormone Deficiency) Reversal Study (reference NIHR127468). Caroline Jones sits on the Paediatric Medicines Expert Advisory Group for the Medicines and Healthcare products Regulatory Agency (January 2017–present).
Funding: {{metadata.Funding}}
{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})
Report Content
The full text of this issue is available as a PDF document from the Toolkit section on this page.
The full text of this issue is available as a PDF document from the Toolkit section on this page.
Responses to this report
No responses have been published.
An error has occurred in processing the XML document